Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 8581 AL 8595

Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease

Frisardi V, Solfrizzi V, Seripa D, Capurso C, Santamato A, Sancarlo D, Vendemiale G, Pilotto A, Panza F.

Ageing Res Rev. 2010 Oct;9(4):399-417. doi: 10.1016/j.arr.2010.04.007. Epub 2010 May 2.

Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo

Darreh-Shori T, Forsberg A, Modiri N, Andreasen N, Blennow K, Kamil C, Ahmed H, Almkvist O, Långström B, Nordberg A.

Neurobiol Aging. 2011 Dec;32(12):2320.e15-32. doi: 10.1016/j.neurobiolaging.2010.04.028. Epub 2010 Jun 9.

Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification

Davatzikos C, Bhatt P, Shaw LM, Batmanghelich KN, Trojanowski JQ.

Neurobiol Aging. 2011 Dec;32(12):2322.e19-27. doi: 10.1016/j.neurobiolaging.2010.05.023. Epub 2010 Jul 1.

[Alzheimer's disease: immunity and diagnosis]

Herrera-Rivero M, Hernández-Aguilar ME, Manzo J, Aranda-Abreu GE.

Rev Neurol. 2010 Aug;51(3):153-64.

Alzheimer disease

Castellani RJ, Rolston RK, Smith MA.

Dis Mon. 2010 Sep;56(9):484-546. doi: 10.1016/j.disamonth.2010.06.001.

Correlation between cognitive impairment and CSF biomarkers in amnesic MCI, non-amnesic MCI, and Alzheimer's disease

Haldenwanger A, Eling P, Kastrup A, Hildebrandt H.

J Alzheimers Dis. 2010;22(3):971-80. doi: 10.3233/JAD-2010-101203.

Plasma cystatin C and risk of developing Alzheimer's disease in subjects with mild cognitive impairment

Ghidoni R, Benussi L, Glionna M, Desenzani S, Albertini V, Levy E, Emanuele E, Binetti G.

J Alzheimers Dis. 2010;22(3):985-91. doi: 10.3233/JAD-2010-101095.

Neurophysiology of Alzheimer's disease: towards understanding the relationship between the EEG phenotype and onset of Alzheimer's disease

Alves TC.

J Neurol Neurosurg Psychiatry. 2011 Jan;82(1):2. doi: 10.1136/jnnp.2010.224030. Epub 2010 Oct 25.

Alzheimer's disease: insights into pathology, molecular mechanisms, and therapy

Zheng Q, Wang X.

Protein Cell. 2025 Feb 1;16(2):83-120. doi: 10.1093/procel/pwae026.

A multifactorial lens on risk factors promoting the progression of Alzheimer's disease

Parker J, Moris JM, Goodman LC, Paidisetty VK, Vanegas V, Turner HA, Melgar D, Koh Y.

Brain Res. 2025 Jan 1;1846:149262. doi: 10.1016/j.brainres.2024.149262. Epub 2024 Oct 5.

Impact of Mouthwash-Induced Oral Microbiome Disruption on Alzheimer's Disease Risk: A Perspective Review

Boulares A, Jdidi H, Bragazzi NL.

Int Dent J. 2025 Feb;75(1):45-50. doi: 10.1016/j.identj.2024.07.005. Epub 2024 Oct 8.

[Prevention Methods for Social Isolation, Loneliness, and Dementia]

Shimoda Y, Urakami K.

Brain Nerve. 2025 Feb;77(2):127-132. doi: 10.11477/mf.188160960770020127.

The Role of Genetic, Environmental, and Dietary Factors in Alzheimer's Disease: A Narrative Review

Mertaş B, Boşgelmez Iİ.

Int J Mol Sci. 2025 Jan 30;26(3):1222. doi: 10.3390/ijms26031222.

[Varicella zoster infection as a risk factor for dementia: a scoping review]

Mori Y, Ono Y, Shimohata T.

Rinsho Shinkeigaku. 2025 Mar 27;65(3):191-196. doi: 10.5692/clinicalneurol.cn-002047. Epub 2025 Feb 22.

Updates on vascular dementia

Ng S, Hornblass A, Habibi P, Ikramuddin S, Chen J, Feng W, Cai D.

Stroke Vasc Neurol. 2025 Oct 27;10(5):542-550. doi: 10.1136/svn-2025-004048.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias